Nancy Kelley has stepped down from her post as founding executive director of the New York Genome Center. Kelley had been the driving force behind the center's creation and last November had also taken on the role of chief operating officer. As reported by PGx Reporter sister publication In Sequence, Kelley will continue to serve as an advisor and remain on the center's board of directors.
Caris Life Sciences has named Joachim Schorr to be its chief scientific officer.
Schorr formerly worked for two decades at Qiagen, where he was senior vice president of global research and development, managing director, and a member of the executive committee, among other positions. He will continue to serve as a scientific consultant for Qiagen.
Prior to joining Qiagen, Schorr worked at Hoechst, a German chemical-pharmaceuticals company, and was also co-founder of Coley Pharmaceuticals, EnPharma Pharmaceuticals, and QBM Cell Sciences.